Tandem Diabetes Care (TNDM) Institutional Ownership

Of the 252 institutional investors that purchased Tandem Diabetes Care's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Sessa Capital IM L.P. ($4.47M), Freestone Grove Partners LP ($2.05M), Hood River Capital Management LLC ($1.53M), Ophir Asset Management Pty Ltd ($1.46M), ArrowMark Colorado Holdings LLC ($1.33M), Assenagon Asset Management S.A. ($1.33M), and First Light Asset Management LLC ($1.31M).

Institutional investors have bought a total of 14,896,223 shares in the last 24 months. This purchase volume represents approximately $269.17M in transactions.

Of the 87 institutional investors that sold Tandem Diabetes Care's stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: BNP Paribas Financial Markets ($9.80M), Assenagon Asset Management S.A. ($1.20M), ArrowMark Colorado Holdings LLC ($801.51K), Royal Bank of Canada ($475.05K), Freestone Grove Partners LP ($427.47K), JPMorgan Chase & Co. ($406.37K), and Trexquant Investment LP ($395.00K).

Institutional investors have sold a total of 18,427,830 shares in the last 24 months. This volume of shares sold represents approximately $273.71M in transactions.